These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2927931)

  • 21. Doses to critical organs from dental radiography.
    Antoku S; Kihara T; Russell WJ; Beach DR
    Oral Surg Oral Med Oral Pathol; 1976 Feb; 41(2):251-60. PubMed ID: 1062754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Persistent chromosome aberrations in the somatic cells of A-bomb survivors, Hiroshima and Nagasaki.
    Awa AA
    J Radiat Res; 1991 Mar; 32 Suppl():265-74. PubMed ID: 1762114
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tooth enamel ESR doses and cytogenetic doses of Nagasaki atomic-bomb survivors in comparison with DS02R1 doses.
    Hirai Y; Cordova KA; Kodama Y; Hamasaki K; Awa AA; Tomonaga M; Mine M; Cullings HM; Nakamura N
    Int J Radiat Biol; 2019 Mar; 95(3):321-328. PubMed ID: 30496019
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cancer and non-cancer effects in Japanese atomic bomb survivors.
    Little MP
    J Radiol Prot; 2009 Jun; 29(2A):A43-59. PubMed ID: 19454804
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk of death among children of atomic bomb survivors after 62 years of follow-up: a cohort study.
    Grant EJ; Furukawa K; Sakata R; Sugiyama H; Sadakane A; Takahashi I; Utada M; Shimizu Y; Ozasa K
    Lancet Oncol; 2015 Oct; 16(13):1316-23. PubMed ID: 26384241
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New dosimetry of atomic bomb radiations.
    Fry RJ; Sinclair WK
    Lancet; 1987 Oct; 2(8563):845-8. PubMed ID: 2889042
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neutron relative biological effectiveness in Hiroshima and Nagasaki atomic bomb survivors: a critical review.
    Sasaki MS; Endo S; Hoshi M; Nomura T
    J Radiat Res; 2016 Nov; 57(6):583-595. PubMed ID: 27614201
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence of leukemia in atomic bomb survivors belonging to a fixed cohort in Hiroshima and Nagasaki, 1950--71. Radiation dose, years after exposure, age at exposure, and type of leukemia.
    Ichimaru M; Ishimaru T; Belsky JL
    J Radiat Res; 1978 Sep; 19(3):262-82. PubMed ID: 739446
    [No Abstract]   [Full Text] [Related]  

  • 29. A review of forty-five years study of Hiroshima and Nagasaki atomic bomb survivors. Theoretical background of the Dosimetry System 86 (D586).
    Kosako T
    J Radiat Res; 1991 Mar; 32 Suppl():11-9. PubMed ID: 1762097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Choice of model and uncertainties of the gamma-ray and neutron dosimetry in relation to the chromosome aberrations data in Hiroshima and Nagasaki.
    Rühm W; Walsh L; Chomentowski M
    Radiat Environ Biophys; 2003 Jul; 42(2):119-28. PubMed ID: 12844221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gamma-ray thermoluminescence measurements: a record of fallout deposition in Hiroshima?
    Egbert SD; Kerr GD
    Radiat Environ Biophys; 2012 May; 51(2):113-31. PubMed ID: 22421931
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RELATIVE BIOLOGICAL EFFECTIVENESS OF NEUTRONS DERIVED FROM THE EXCESS RELATIVE RISK MODEL WITH THE ATOMIC BOMB SURVIVORS DATA MANAGED BY HIROSHIMA UNIVERSITY.
    Satoh K; Yasuda H; Kawakami H; Tashiro S
    Radiat Prot Dosimetry; 2018 Aug; 180(1-4):346-350. PubMed ID: 29036656
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Salivary gland tumors among atomic bomb survivors, 1950-1987.
    Saku T; Hayashi Y; Takahara O; Matsuura H; Tokunaga M; Tokunaga M; Tokuoka S; Soda M; Mabuchi K; Land CE
    Cancer; 1997 Apr; 79(8):1465-75. PubMed ID: 9118025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psychiatric sequelae in atomic bomb survivors in Hiroshima and Nagasaki two decades after the explosions.
    Yamada M; Izumi S
    Soc Psychiatry Psychiatr Epidemiol; 2002 Sep; 37(9):409-15. PubMed ID: 12242616
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neutrons at Hiroshima: how their disappearance affected risk estimates.
    Ellett WH
    Radiat Res; 1991 Oct; 128(1 Suppl):S147-52. PubMed ID: 1924742
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radiation-related posterior lenticular opacities in Hiroshima and Nagasaki atomic bomb survivors based on the DS86 dosimetry system.
    Otake M; Schull WJ
    Radiat Res; 1990 Jan; 121(1):3-13. PubMed ID: 2300666
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An analysis of various aspects of atomic bomb dose estimation at RERF using data on acute radiation symptoms.
    Gilbert ES; Ohara JL
    Radiat Res; 1984 Oct; 100(1):124-38. PubMed ID: 6494426
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thermoluminescence dosimetry of gamma rays from the atomic bomb at Hiroshima using the predose technique.
    Nagatomo T; Ichikawa Y; Ishii H; Hoshi M
    Radiat Res; 1988 Feb; 113(2):227-34. PubMed ID: 3340729
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Absorbed doses from intraoral radiography with special emphasis on collimator dimensions.
    Stenström B; Henrikson CO; Holm B; Richter S
    Swed Dent J; 1986; 10(1-2):59-71. PubMed ID: 3458320
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between the radiation dose and chromosome aberrations in atomic bomb survivors of Hiroshima and Nagasaki.
    Awa AA; Sofuni T; Honda T; Itoh M; Neriishi S; Otake M
    J Radiat Res; 1978 Jun; 19(2):126-40. PubMed ID: 712662
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.